CMMHOSP.BO · BSE
CHENNAI MEENAKSHI MULTISPECIAL
₹38.9
+3.05% (+₹1.15)
Prev. close
₹37.75
Volume
204
As of
BSE · may be slightly delayed · 15:25 IST
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About CHENNAI MEENAKSHI MULTISPECIAL
Chennai Meenakshi Multispeciality Hospital Limited operates a multi-specialty hospital in Chennai, India. It also sells pharmacy products. The company was formerly known as Devaki Hospital Limited and changed its name to Chennai Meenakshi Multispeciality Hospital Limited in November 2007. Chennai Meenakshi Multispeciality Hospital Limited was incorporated in 1990 and is based in Chennai, India.
Details
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Ms. Gomathi Radhakrishnan
Headquarters
Chennai
Employees
223
Website
cmmh.inExchange
View on BSE ↗Key stats
Market cap
₹28.20 Cr
EPS (TTM)
₹-0.50
Beta (1Y · daily vs NIFTY 50)
0.48
Beta (5Y · monthly vs NIFTY 50)
1.57
Shares float
26.47 L
EPS · quarter ended Jun 2026
₹0.00
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Debt/equity omitted where reported equity was zero or negative. Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹38.61 Cr | ₹38.05 Cr | ₹34.82 Cr | ₹37.04 Cr | |
| EBITDA | ₹3.21 Cr | ₹2.02 Cr | ₹64.90 L | ₹84.19 L |
| ₹89.05 L | ₹-42.74 L | ₹-1.43 Cr | ₹-1.12 Cr | |
| Diluted EPS | ₹1.19 | ₹-0.57 | ₹-1.84 | ₹-1.5 |
Total expenses (as filed), Employee benefit expense, Other expenses have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹22.10 Cr | ₹22.81 Cr | ₹22.51 Cr | ₹21.24 Cr | |
| ₹10.63 Cr | ₹11.42 Cr | ₹10.63 Cr | ₹10.63 Cr | |
| Stockholders' equity | ₹12.16 L | ₹-32.75 L | ₹-1.89 Cr | ₹-3.08 Cr |
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹2.95 Cr | ₹2.09 Cr | ₹2.17 Cr | ₹36.65 L | |
| Investing cash flow | ₹-1.91 Cr | ₹-1.86 Cr | ₹-75.11 L | ₹-1.62 Cr |
| ₹-74.52 L | ₹3.14 L | ₹-1.56 Cr | ₹-74.45 L | |
| Capital expenditure | ₹-1.09 Cr | ₹-2.21 Cr | ₹-27.27 L | ₹-9.91 L |
| End cash position | ₹2.53 Cr | ₹2.79 Cr | ₹2.65 Cr | ₹64.48 L |
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,846.4 | 37.1 | 5.37 | 13.7% | 0.06 | +11.9% | +12.3% |
| Divi's Laboratories Limited | ₹2.49 L Cr | ₹9,410.5 | 84.7 | 14.85 | 15.3% | 0.00 | +12.3% | +51.8% |
| Torrent Pharmaceuticals Limited | ₹1.84 L Cr | ₹4,970 | 77.5 | 21.95 | 25.8% | 1.79 | +21.5% | +36.9% |
| Apollo Hospitals Enterprise Limited | ₹1.28 L Cr | ₹8,835.5 | 61.5 | 13.52 | 20.5% | 0.90 | +15.7% | +14.2% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹691.45 | 179.0 | 13.55 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.16 L Cr | ₹1,161 | 25.8 | 4.27 | 18.6% | 0.46 | +18.4% | +11.9% |
| Cipla Limited | ₹1.12 L Cr | ₹1,384.1 | 33.2 | 3.25 | 11.3% | 0.02 | +2.1% | -10.3% |
| Laurus Labs Limited | ₹1.09 L Cr | ₹2,006.5 | 99.3 | 20.57 | 16.8% | 0.48 | +22.0% | +122.0% |
| Max Healthcare Institute Limited | ₹1.02 L Cr | ₹1,066.6 | 70.4 | 9.50 | 13.4% | 0.32 | +19.0% | -8.0% |
| Manipal Health Enterprises Limited | ₹99,047.90 Cr | ₹746.1 | 152.1 | 11.75 | 7.8% | 1.53 | +18.0% | — |
| Dr. Reddy's Laboratories Limited | ₹98,709.15 Cr | ₹1,198.3 | 29.8 | 2.62 | 11.4% | 0.21 | +3.2% | -9.3% |
| CHENNAI MEENAKSHI MULTISPECIAL | ₹27.69 Cr | ₹37.08 | — | — | — | — | +6.4% | -21.9% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 30
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.